Where is Graybug Vision, Inc.'s headquarters located?

Graybug Vision, Inc.'s main headquarters is located at 203 Redwood Shores Parkway Suite 620 Redwood City, California 94065 United States.

What is Graybug Vision, Inc.'s phone number?

You can contact Graybug Vision, Inc.'s main corporate office by phone at +1-650-487-****.

What is Graybug Vision, Inc.'s official website and social media links?

Graybug Vision, Inc.'s official website is graybug.vision. Graybug Vision, Inc. has social profiles on LinkedIn.

How many employees does Graybug Vision, Inc. have currently?

Graybug Vision, Inc. has approximately 32 employees.

What industry does Graybug Vision, Inc. belong to?

Graybug Vision, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Graybug Vision, Inc. use?

Graybug Vision, Inc.'s tech stack includes PHP, Modernizr, Web Vitals, Webpack, Akamai.

How much funding has Graybug Vision, Inc. raised to date?

Graybug Vision, Inc. has raised $80M in funding. The last funding round occurred on Aug 20, 2019 for $80M.

When was Graybug Vision, Inc. founded?

Graybug Vision, Inc. was founded in 2011.

What is Graybug Vision, Inc.'s NAICS code?

Graybug Vision, Inc.'s NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Graybug Vision, Inc. Email Formats	Example	Percentage
FLast@graybug.com	JDoe@graybug.com	84%
First.Last@graybug.com	John.Doe@graybug.com	8%
Last@graybug.com	Doe@graybug.com	5%
First@graybug.com	John@graybug.com	3%
Last@graybug.vision	Doe@graybug.vision	60%
FLast@graybug.vision	JDoe@graybug.vision	40%

Graybug Vision, Inc.

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Every day, Graybug Vision works relentlessly to make healthy vision more accessible and more manageable for patients with chronic vision-threatening eye diseases. We are a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of chronic diseases of the retina and optic nerve. Our novel technologies are designed to release drugs in ocular tissue at a controlled rate for up to 12 months in order to improve patient compliance, reduce healthcare burdens and, ultimately, deliver better clinical outcomes.

Graybug Vision was founded in 2011 as a spin-out of the world-renowned Wilmer Eye Institute of the Johns Hopkins University School of Medicine. Based on Graybug's proprietary technologies, our R&D pipeline targets a range of chronic vision-threatening diseases, such as wet age-related macular degeneration and primary open angle glaucoma.

To learn more about who we are and what we solve for with our technologies and pipeline, please visit our website.

Insights

Similar companies to Graybug Vision, Inc.

Ocular Therapeutix, Inc.

Apellis Pharmaceuticals

Kodiak Sciences

Iveric Bio

REGENXBIO Inc.

Adverum Biotechnologies

Annexon Biosciences

Alimera